In the high-stakes arena of orthopedic trauma surgery, the Intramedullary (IM) Nail System stands as the gold standard for treating long bone fractures. As the global population ages and traumatic injury cases from industrialization rise, the demand for sophisticated internal fixation devices has surged. At Synoviq Medical Technology, we recognize that an IM nail is more than a piece of titanium; it is a bio-mechanical bridge that restores mobility and life quality.
From a macro-industrial perspective, the shift from traditional plate fixation to intramedullary nailing represents a paradigm shift toward Minimally Invasive Surgery (MIS). This transition reduces blood loss, preserves the biological environment of the fracture site (the "biological internal fixation" concept), and allows for earlier weight-bearing. As a leading China-based manufacturer, Synoviq is at the epicenter of this transformation, blending cost-efficiency with uncompromising Swiss-type precision.
Our Intramedullary Nail Systems are engineered using medical-grade Titanium Alloy (Ti6Al4V ELI) and high-strength Stainless Steel, adhering to ASTM F136 and ISO 5832-3 standards. But expertise goes beyond material choice.
Optimized nail stiffness and anatomical curvature reduce stress shielding and prevent secondary fractures. Our PFNA (Proximal Femoral Nail Antirotation) systems utilize a helical blade design to provide superior stability in osteoporotic bone.
Advanced Type II anodization increases surface hardness and fatigue resistance while maintaining excellent biocompatibility. This ensures long-term implant stability and minimizes metal ion release.
Every nail system is supported by a bespoke instrument set designed for ergonomic handling and radiographic transparency, ensuring precise alignment and locking screw placement under C-arm guidance.
Navigating the regulatory landscape of medical devices is a core competency of Synoviq. As a Class III medical device manufacturer, we provide comprehensive documentation support for international markets, including CE, ISO 13485, and localized registration assistance.
| Compliance Pillar | Description & Implementation | Benefits to Distributors |
|---|---|---|
| Quality Control | 100% Final Inspection via CMM and Mechanical Stress Testing. | Zero-defect shipments, reducing liability and returns. |
| Traceability | Unique Device Identification (UDI) laser marking on every implant. | Full lifecycle tracking from raw material to patient. |
| MDR/FDA Support | Preparation of technical files and clinical evaluation reports. | Faster market entry in Europe and North America. |
| OEM/ODM Flexibility | Customized designs, packaging, and branding (private label). | Building local brand equity with factory-direct pricing. |
Our systems are designed for diverse clinical environments. In advanced hospitals, our Expert Interlocking Systems facilitate rapid surgery using navigation. In emerging markets, we provide simplified, robust instrument sets that are easy to maintain and sterilize, ensuring that high-quality orthopedic care is accessible globally.
Spanning 18,600 m², our facility is a testament to intelligent manufacturing. We employ 76 R&D engineers who bridge the gap between surgical feedback and industrial production.
Our QC department (48 dedicated staff) utilizes advanced Automatic 2D Video Measuring Instruments, Tensile Testing Machines, and Spectrometers to ensure that every batch of material and every finished product exceeds clinical expectations. We don't just follow standards; we set them.
| Established | March 18, 2016 (14 Years Industry Experience) |
| Building Area | 18,600 m² modern clean production facility |
| Quality Inspection | CMM Measurement, Mechanical Testing, Sterility Validation |
| Main Markets | Europe, North America, South America, Middle East, Asia-Pacific |
| R&D Strength | 76 Engineers; 186 New Products Released last year |
Synoviq Medical
